|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 403/04 | (2006.01) |
| C07D 403/14 | (2006.01) | ||
| A61K 31/404 | (2006.01) | ||
| A61K 31/4178 | (2006.01) | ||
| A61P 11/00 | (2006.01) |
| (11) | Number of the document | 3071561 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14864293.7 |
| Date of filing the European patent application | 2014-11-20 | |
| (97) | Date of publication of the European application | 2016-09-28 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-24 |
| (46) | Date of publication of the claims translation | 2021-08-25 |
| (86) | Number | PCT/US2014/066706 |
| Date | 2014-11-20 |
| (87) | Number | WO 2015/077503 |
| Date | 2015-05-28 |
| (30) | Number | Date | Country code |
| 201361907965 P | 2013-11-22 | US | |
| 201462038121 P | 2014-08-15 | US |
| (72) |
HUTCHINSON, John, Howard, US
LONERGAN, David, US
|
| (73) |
Sabre Therapeutics LLC,
442 Littlefield Avenue, South San Francisco, CA 94080,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Autotaksino inhibitorių junginiai |
| AUTOTAXIN INHIBITOR COMPOUNDS |
| Payment date | Validity (years) | Amount | |
| 2025-10-31 | 12 | 289.00 EUR |
| 2026-11-20 |